Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection

(2012) Mika Kurokawa et al.   JOURNAL OF GASTROENTEROLOGY

Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma

(2011) Chuen–Fei Chen et al.   GASTROENTEROLOGY

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

(2011) Hwai-I Yang et al.   LANCET ONCOLOGY

Long-Term Nucleos(t)ide Analogues Therapy for Adults With Chronic Hepatitis B reduces the Risk of Long-Term Complications: a meta-analysis

(2011) Qin-Qin Zhang et al.   Virology Journal

Hepatitis B virus DNA levels and outcomes in chronic hepatitis B

(2010) Chien-Jen Chen et al.   HEPATOLOGY

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers

(2010) Vincent Wai-Sun Wong et al.   JOURNAL OF CLINICAL ONCOLOGY

Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection

(2010) Hwai-I Yang et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection

(2010) Osamu Yokosuka et al.   JOURNAL OF HEPATOLOGY

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review

(2010) George V. Papatheodoridis et al.   JOURNAL OF HEPATOLOGY

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

(2008) Man-Fung Yuen et al.   JOURNAL OF HEPATOLOGY